Please login to bookmarkClose

Poppy processor Palla Pharma has agreed to pay $1.125 million to rival Tasmanian Alkaloids t0 settle a lawsuit alleging infringement of two innovation patents for high codeine-concentrated poppy.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au